Healthcare Global Q3 FY26: Net loss Rs 7.9 cr

What Healthcare Global reported for Q3 FY26

Healthcare Global Enterprises Ltd (HCG) reported a loss at the net level in Q3 FY25-26, even as revenue stayed in the mid-600-crore range. The company’s Q3 FY26 standalone profit after tax was reported at Rs -7.90 crore. A separate snapshot in the provided data also lists net profit as Rs -7 crore, which aligns with the rounded figure for the quarter. The earnings date for the quarter is listed as 5 February 2026. The update matters because it shows a sharp sequential reversal from a profit in the previous quarter.

Revenue trend: modest YoY growth, slight QoQ dip

For Q3 FY26, HCG’s revenue is cited as Rs 635.54 crore in one summary, while another line reports net sales of Rs 633.07 crore. The dataset also shows revenue of 633 with -2.13% QoQ and 13.34% YoY growth. Taken together, the numbers indicate that revenue growth held up year-on-year but weakened quarter-on-quarter. The article text explicitly notes Q3 FY26 net sales at Rs 633.07 crore, up 13.34% YoY but down 2.13% sequentially from Q2 FY26’s Rs 646.85 crore.

Profitability swung to a loss

The quarter showed a sharp deterioration in profitability compared with Q2 FY26. The provided text states HCG moved from a Rs 16.27 crore profit in Q2 FY26 to a consolidated net loss of Rs -9.43 crore in Q3 FY26. On the standalone side, the quarter’s profit after tax is stated at Rs -7.90 crore, compared with Rs 20.66 crore in Q2 FY26 and Rs 7.75 crore in Q3 FY25. The narrative also attributes part of the pressure to higher financial charges and depreciation, which “wiped out” operating profit at the net level.

Margin and gross profit pressure showed up in the quarter

The dataset lists gross profit of 48 (unit not specified in the snippet) with -19.09% QoQ and 53.67% YoY. It also states that gross profit margin in Q3 FY26 stood at 8.66%, down from 12.76% in Q2 FY26, pointing to cost pressure. Separately, a table of operating margin percentages shows 17.37% for Dec’25 (Q3 FY26), versus 19.11% in Sep’25 (Q2 FY26). These points together indicate the quarter faced both pricing or mix pressure and cost headwinds.

Exceptional items linked to labour code changes

The article text explicitly flags exceptional costs related to regulatory-driven labour code changes. It states that standalone net loss for Q3 FY26 was Rs 1.18 crore, with a consolidated net loss of Rs 9.43 crore attributable to owners, mainly due to exceptional labour code-related costs. It further states exceptional items in Q3 FY26 were Rs 7.86 crore (standalone) and Rs 12.67 crore (consolidated) due to labour code changes. These figures are presented as a key driver behind the quarter’s reported loss.

Profit before tax and tax movement

Another set of quarter details in the text reports profit before tax of Rs -6.02 crore in Q3 FY26, compared with Rs 19.51 crore in the previous quarter. Tax expense is stated at Rs 1.83 crore for Q3 FY26, compared with a tax benefit of Rs -0.84 crore in Q2 FY26 and Rs -11.05 crore in Q3 FY25. Based on this, profit after tax is stated at Rs -7.90 crore for Q3 FY26. The same section describes the quarterly and annual decline in profitability as substantial.

Standalone March 2026 quarter numbers also showed a loss

The provided text also includes standalone quarterly numbers for the March 2026 quarter. It reports net sales at Rs 603.21 crore in March 2026, up 12.42% from Rs 536.58 crore in March 2025. It also reports a quarterly net loss of Rs 163.19 crore in March 2026 versus Rs 61.68 crore in March 2025. EBITDA for March 2026 is described as negative at Rs 125.70 crore, compared with Rs 5.04 crore in March 2025.

Key numbers table

Market impact: what the quarter’s numbers indicate

The quarter’s data points show that HCG’s revenue held up but did not translate into profits. The sequential swing from a profit to a loss is explicitly highlighted in the text and is reinforced by the stated QoQ deterioration percentages. Margin compression is also directly stated through the drop in gross profit margin and operating margin percentage. For investors, the key takeaway from the provided information is that the earnings outcome was affected by cost pressures and exceptional items, rather than a collapse in revenue.

Why this quarter matters in context

The Q3 FY26 result stands out because the company reported a positive net profit in Q2 FY26, but moved back into loss in Q3 FY26. The data also provides a clear explanation for at least part of the pressure: exceptional costs driven by labour code-related regulatory changes. Alongside this, the text points to higher depreciation and interest expense from growth investments and acquisitions as a factor that reduced profit after tax in another quarter comparison (PAT of Rs 4.73 crore versus Rs 12.08 crore, as stated). Within the information provided, the quarter therefore reflects a combination of operating and non-operating pressures.

Conclusion

Healthcare Global Enterprises’ Q3 FY25-26 performance showed steady revenue but a sharp hit to profitability. The company reported standalone net profit of Rs -7.90 crore for the quarter, while consolidated net profit is stated at Rs -9.43 crore, with exceptional labour code-related costs cited as a key reason. The earnings date for the quarter is listed as 5 February 2026, and the next earnings date mentioned in the data is 19 May 2026. Future updates will likely be tracked for how margins and exceptional items evolve in subsequent quarters.